Amylx Pharmaceuticals Inc vs Unilever plc — how do they compare? Amylx Pharmaceuticals Inc trades at $23.65 (market cap $2.64B), while Unilever plc trades at $61.88 (market cap $134.06B). The key difference: Unilever plc is far larger — about 50.8× Amylx Pharmaceuticals Inc's market cap, and Unilever plc pays a 3.65% dividend while Amylx Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| AMLX | UL | |
|---|---|---|
Market Cap | $2.64B | $134.06B |
Sector | Health | Consumer Staples |
52-Week High | $24.19 | $74.59 |
52-Week Low | $7.82 | $55.05 |
Enterprise Value | $2.39B | $159.86B |
Dividend Yield | — | 3.65% |
Signals from Pluang's Aura AI — not financial advice
AMLX trades at $22.82, down 5.66% on the day, with a bullish technical signal from moving averages and key support at $22. The company reported a net loss of -$144.74M for 2025, with negative ROE and ROA, but holds a $250.8M cash runway into 2028. The pivotal Phase 3 LUCIDITY trial for avexitide is set for a late August/early September 2026 readout, a key near-term catalyst.
Analyst consensus is strongly bullish with a $30.00 price target, though recent earnings misses and negative cash flow from operations in 2026 pose risks. The stock's outlook hinges on successful clinical trial results and the subsequent regulatory pathway for its lead endocrine asset.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
Amylyx Pharmaceuticals is a biopharmaceutical firm focused on developing therapies for rare diseases. Its pipeline includes treatments for conditions like post-bariatric hypoglycemia and congenital hyperinsulinism.
Read more on AMLX →Unilever is a diversified personal product (42% of 2021 sales by value), home care (20%), and packaged food (38%) company. Its brands include Knorr soups and sauces, Hellmann's mayonnaise, Lipton teas, Axe and Dove skin products, and the TRESemme haircare brand. The firm has been acquisitive in recent years
Read more on UL →